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INTRODUCTION
Hypersensitivity pneumonitis is a rare interstitial disorder characterized by an
immune reaction of the lung parenchyma, usually to a sensitized allergen.
Pneumonitis is a common cause of respiratory decline among those with
comorbid conditions such as chronic obstructive pulmonary disease and
congestive heart failure. The use of corticosteroids in patients with pneumonitis
is well documented, but their role in the treatment is not clearly understood.
The primary objective of this study was to observe and describe clinical
improvement of a patient with pneumonitis after a short course of
corticosteroids while in the hospital.

CASE PRESENTATION
Patient is a 58-year-old female who presents with a three-day history of
progressive shortness of breath, nonproductive cough, dyspnea on
exertion, orthopnea, and weight gain. Past medical history includes
polymyalgia rheumatica, hypothyroidism,
osteoporosis, current
hormone replacement therapy, and current smoker with a 70-pack-year
smoking history. Family history is significant for lung cancer.
Given the patient's previous history, initial concerns were for COPD
exacerbation, congestive heart failure, bronchiectasis, interstitial lung
disease, and community-acquired pneumonia. On admission, the
patient presented with SpO2 of 86% on 3 L nasal cannula and
subsequently was diagnosed with respiratory failure with hypoxia.
Patient was started on 4-5 L nasal cannula. Due to desaturation the
patient required adjustment 10 L high flow nasal cannula. Blood gas on
admission showed pH 7.418, PCO2 37.8, PO2 62, bicarb 24. CBC
showed leukocytosis. D-dimer 1.68, ESR 90, CRP 20, LDH 960, and
BNP of 1456. Blood cultures on admission showed no growth at 120
hours. CXR on admission showed diffuse densities throughout both
lungs. CTA pulmonary showed no evidence of acute pulmonary emboli,
but ground glass opacities were present. The patient was started on
Lasix, IV Solu-Medrol, Cefepime, and Vancomycin.
On day two, the chest x-ray revealed mild improvement of aeration,
small effusions with no pneumothorax. Antibiotics were discontinued on
day two and steroids were increased on day three. The patient's
deteriorating respiratory status improved, with resolution of symptoms
within five days. Repeat CXR on day six showed low lung volumes with
a mild pulmonary edema pattern. Repeat CTPA conducted on day six
showed nearly resolved pneumonia with improving adenopathy. Repeat
BNP was 173. The patient was discharged on oral prednisone taper.
Since then, the patient has been doing well with outpatient follow up
and remains off oxygen.

Hypersensitivity pneumonitis (HP), also known as extrinsic allergic alveolitis
(EAA), is a syndrome that affects the lung parenchyma as well as the alveolar
interstitium. (5) This area becomes inflamed in response to a previously
sensitized organic antigen after prolonged exposure. This antigen is usually a
naturally occurring material such as mold, bird droppings, chemics, etc.
Depending on the material causing the reaction as well as the length of time of
exposure HP may be categorized as acute, subacute, or chronic. However, the
lack of widely accepted diagnostic criteria makes it difficult to properly
diagnose a patient with HP.
The common symptoms in hypersensitivity pneumonitis include coughing,
dyspnea, fever and malaise may also be seen. Classic features on imaging
include ground-glass opacities, areas of decreased attenuation and
vascularity, and small centrilobular nodules. (3) A common presentation of
acute HP is exacerbation of the symptoms when returning to the area of
exposure, and an improvement in symptoms once the patient leaves the area
of exposure. Chronic HP, in contrast, can develop over months to years,
presenting with episodes of wheezing and low-grade fevers. In severe cases,
chronic HP can cause anorexia, weight loss, dyspnea, and mucopurulent
sputum. As such, it is important to be aware of the signs and symptoms of this
disease early in its course, as untreated HP has the potential to lead to
overwhelming outcomes.
This case demonstrates the rapid resolution of hypersensitivity pneumonitis in
response to steroids. Although hypersensitivity pneumonitis is typically
associated with microbial agents, animal proteins and droppings, or chemical
exposure, the immune mediated response is often obscured by smoking and
can often be missed on presentation. This patient's rapid response and
recovery to steroids and lack of response to antibiotics and diuretics quickly
narrowed down the differential to exclude congestive heart failure, COPD
exacerbation, and pneumonia. While the presence of the ground-glass
opacities is a common, nonspecific imaging finding on CT in a variety of
pulmonary diseases including cardiogenic pulmonary edema, extra cardiac
causes including hypersensitivity like reaction, eosinophilic pneumonias, and
atypical infectious processes such as pneumocystis pneumonia the clinical
course supports the diagnosis of hypersensitivity pneumonitis.
The gold standard treatment remains antigen avoidance with follow up
imaging to evaluate for improvement. Imaging with high-resolution CT scan
has been shown to be successful in imaging hypersensitivity pneumonitis.
Total avoidance, however, can prove to be quite difficult as the antigen in
question may be present in the job or a home. (2) As a result, corticosteroids
(typically prednisone) 40mg or 60mg over four weeks are indicated for acute
flare ups. Unfortunately, chronic HS unresponsive to corticosteroids can lead
to a pulmonary fibrosis, at which time a lung transplant can be considered. (4)
The patient’s rapid recovery on steroids for presumed interstitial lung disease
related to hypersensitivity reaction from her smoking history presents a unique
presentation and approach to treatment. Cigarette smoking can affect the
physical examination findings, erythrocyte sedimentation rate, and spirometry,
making it difficult to rely on these testing modalities. The entire clinical course
with radiological evidence is the most appropriate method of diagnosis (1).
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Figure 2

HRCT Day 1 showed patient
with ground-glass opacities
bilaterally along with
centrilobular nodules and air
trapping.

HRCT Day 6 showed essentially
resolved HP with improving
aeration, low lung volumes, and
improved adenopathy.

CONCLUSION
The authors present this case to emphasize the challenging differential
diagnosis of hypersensitivity pneumonitis due to the lack of specificity of
clinical manifestations and treatment. A multidisciplinary discussion of
clinical and radiologic data can play a role in the diagnosis and thus early
and effective management of rapid respiratory deterioration. The diagnosis
requires attention to exposure history, clinical assessment, and radiographic
findings. Clinicians should have a high suspicion for hypersensitivity
pneumonitis in chronic smokers.
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